The MTHFR c.665TT genotype, encoding the thermolabile enzyme with a lower affinity for its cofactor, flavin adenine dinucleotide (FAD), has been associated with an increased risk of lung cancer in populations analysed as a whole [18–20, 22] and in the subgroups: of patients with earlier onset or low folate intake [16], in women [17] and in squamous and small cell lung carcinomas [15]. The gene discussed is MTHFR; the disease is lung carcinoma.